reference/10600888

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10600888

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1232
issn	1557-7422 1043-0342
issueIdentifier	12
pageRange	1225-1232
publicationName	Human Gene Therapy
startingPage	1225
bibliographicCitation	Shirakawa T, Terao S, Hinata N, Tanaka K, Takenaka A, Hara I, Sugimura K, Matsuo M, Hamada K, Fuji K, Okegawa T, Higashihara E, Gardner TA, Kao C, Chung LW, Kamidono S, Fujisawa M, Gotoh A. Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. Hum Gene Ther. 2007 Dec;18(12):1225–32. doi: 10.1089/hum.2007.074. PMID: 18021019.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91268834f02d0a639dcddca6d60d2f59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54cfb5202606f2d242be9ee26cc31b7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf774ffc5cead5d31aca823139eed39a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78d1d80e83e144884142b0a6484ce31a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aad1537aa9348504f0deeb8579ea093 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bb32aacf4634cc0cc59613094f4720d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_270f0e5e186588ed886955830e24bb3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17e42c2e11c2aa2de6e6385fc942a6ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e41a56ce12aff891246c10385e7b00c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f5dc5942e50e455ac0736f16f036d3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37ef83176a82198a5a9331894abd949a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88dcd9fa3a47f1392a1eb6c5e33968c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1652f392d1a7fdc4f7d4c6f480c2fb59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a3b610a3075c28c6d646b3c704fdc2c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_521aa8ffd6d64b6024149976f19a7484 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cb60e0ad9348127a62ff8878ef9d0c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfd4150bf89a54960a11421267a7db7c
date	200712
identifier	https://pubmed.ncbi.nlm.nih.gov/18021019 https://doi.org/10.1089/hum.2007.074
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1041 https://portal.issn.org/resource/ISSN/1557-7422 https://portal.issn.org/resource/ISSN/1043-0342
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Long-Term Outcome of Phase I/II Clinical Trial of Ad-OC-TK/VAL Gene Therapy for Hormone-Refractory Metastatic Prostate Cancer
discusses	http://id.nlm.nih.gov/mesh/M0224608 http://id.nlm.nih.gov/mesh/M0024030 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0021448 http://id.nlm.nih.gov/mesh/M0000326 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0026444 http://id.nlm.nih.gov/mesh/M0001103
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015675Q000235 http://id.nlm.nih.gov/mesh/D015316Q000009 http://id.nlm.nih.gov/mesh/D013937Q000235 http://id.nlm.nih.gov/mesh/D011471Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000998Q000008 http://id.nlm.nih.gov/mesh/D014633Q000008 http://id.nlm.nih.gov/mesh/D017430Q000097 http://id.nlm.nih.gov/mesh/D000256Q000235 http://id.nlm.nih.gov/mesh/D000212Q000031 http://id.nlm.nih.gov/mesh/D000212Q000008 http://id.nlm.nih.gov/mesh/D000726Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011401 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D014633Q000031 http://id.nlm.nih.gov/mesh/D043823Q000627 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D011859 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D000077483 http://id.nlm.nih.gov/mesh/D001842Q000000981 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001859Q000000981 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005822Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8015 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.77 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.1.21 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398742 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259331

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127889566 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128204655 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610196 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128045545

Total number of triples: 92.